Over her 40-year career, Kelley Hill has become regarded as an industry expert in strategic, high-quality, and impactful regulatory writing, especially in the rare disease space. Now enjoying a slower pace of life having retired in 2023, she has led highly successful writing departments in pharma, including at Shire, Certara, and, most recently, Alexion, and contract research organisations. Medical Writing guest editor Sarah Milner asked her about her experience as a writer in rare disease over the years.   Medical Writing. 2025;34(1):22–23. https://doi.org/10.56012/gfym3039